EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the In Vitro Activity of Bedaquiline, Delamanid, and Clofazimine Against Mycobacterium abscessus Complex and Their Antibiofilm Potential

Katarzyna Kania, Katarzyna Wójcik, Alicja Skórkowska, Karolina Klesiewicz iD

Pathogens · 2025

DOI: 10.3390/pathogens14060582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Katarzyna Kania und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, St. Medyczna 9, 30-688 Krakow, Poland. Hauptthemen laut MEDLINE: Biofilms, Clofazimine, Diarylquinolines, Mycobacterium abscessus. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jagiellonian University Medical College, Jagiellonian University, Priority Research Area qLIFE under the Strategic Programme Excellence Initiative at Jagiellonian University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium abscessus complex (MABc) poses a major therapeutic challenge due to its intrinsic multidrug resistance and ability to form biofilms. This study evaluated the in vitro activity of three antimycobacterial agents—bedaquiline, delamanid, and clofazimine—on 20 clinical MABc isolates, including M. abscessus subsp. abscessus, massiliense, and bolletii, with a focus on biofilm-forming phenotypes. Biofilm analysis showed that the rough colony morphotypes were mostly weak biofilm formers, while the smooth and mixed morphotypes were predominantly moderate or strong biofilm formers. A statistically significant association was observed between the mixed colony morphology and strong biofilm formation (p = 0.032). Importantly, bedaquiline exhibited potent and consistent activity across all isolates, regardless of the biofilm-forming ability, with MIC values ranging from 0.125 to 1 µg/mL. In contrast, delamanid and clofazimine showed limited efficacy, with MIC values exceeding 16 µg/mL and 8 µg/mL, respectively. These findings strongly support the role of bedaquiline as a promising core agent for future combination therapies targeting drug-resistant MABc infections, including biofilm-associated infections. Our results, among the first from Poland, highlight the critical need for incorporating novel agents such as bedaquiline into therapeutic strategies against this difficult-to-treat pathogen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsClofazimineDiarylquinolinesMycobacterium abscessusOxazolesNitroimidazolesMycobacterium Infections, NontuberculousAntitubercular AgentsAnti-Bacterial AgentsMicrobial Sensitivity TestsHumans

Stichwörter der Autor:innen

Mycobacterium abscessus complexbedaquilinebiofilm formationnon-tuberculous mycobacteria

Substanzen

bedaquilineClofazimineDiarylquinolinesOPC-67683OxazolesNitroimidazolesAntitubercular AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, St. Medyczna 9, 30-688 Krakow, Poland.
  • Laboratory of Microbiology, The St. John Paul II Specialist Hospital, St. Pradnicka 80, 31-202 Krakow, Poland.
  • Malopolska Central Laboratory of Tuberculosis Diagnostics, The St. John Paul II Specialist Hospital, St. Ulanow 29, 31-455 Krakow, Poland.
  • BioImaging Laboratory, Center for the Development of Therapies for Civilization and Age-Related Diseases, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.

ORCID-Profile: Karolina Klesiewicz

Förderung

  • Jagiellonian University Medical College
  • Jagiellonian University
  • Priority Research Area qLIFE under the Strategic Programme Excellence Initiative at Jagiellonian University
  • Smart Growth Operational Programme POIR 4.2

Zitieren

APA

Kania, K., Wójcik, K., Skórkowska, A., & Klesiewicz, K. (2025). Evaluation of the In Vitro Activity of Bedaquiline, Delamanid, and Clofazimine Against Mycobacterium abscessus Complex and Their Antibiofilm Potential. Pathogens. https://doi.org/10.3390/pathogens14060582

Vancouver

Kania K, Wójcik K, Skórkowska A, Klesiewicz K. Evaluation of the In Vitro Activity of Bedaquiline, Delamanid, and Clofazimine Against Mycobacterium abscessus Complex and Their Antibiofilm Potential. Pathogens. 2025. doi:10.3390/pathogens14060582

BibTeX
@article{Kania2025,
  author = {Kania, Katarzyna and Wójcik, Katarzyna and Skórkowska, Alicja and Klesiewicz, Karolina},
  title = {Evaluation of the In Vitro Activity of Bedaquiline, Delamanid, and Clofazimine Against Mycobacterium abscessus Complex and Their Antibiofilm Potential},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14060582}
}
Kostenlos starten →